These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30763188)

  • 1. Residual Disease after Neoadjuvant Therapy - Developing Drugs for High-Risk Early Breast Cancer.
    Prowell TM; Beaver JA; Pazdur R
    N Engl J Med; 2019 Feb; 380(7):612-615. PubMed ID: 30763188
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical usefulness and relevance of intermediate endpoints for cytotoxic neoadjuvant therapy.
    Fontanella C; Loibl S; von Minckwitz G
    Breast; 2015 Nov; 24 Suppl 2():S84-7. PubMed ID: 26279131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy.
    Ladoire S; Arnould L; Mignot G; Coudert B; Rébé C; Chalmin F; Vincent J; Bruchard M; Chauffert B; Martin F; Fumoleau P; Ghiringhelli F
    Breast Cancer Res Treat; 2011 Jan; 125(1):65-72. PubMed ID: 20229175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herceptin (trastuzumab): adjuvant and neoadjuvant trials.
    Yaal-Hahoshen N; Safra T
    Isr Med Assoc J; 2006 Jun; 8(6):416-21. PubMed ID: 16833172
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization and clinical impact of residual disease after neoadjuvant chemotherapy.
    Viale G
    Breast; 2013 Aug; 22 Suppl 2():S88-91. PubMed ID: 24074800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant endocrine therapy for postmenopausal estrogen receptor-positive patients with breast cancer].
    Zhang B
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):241-4. PubMed ID: 21575491
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathologic evaluation of breast cancer specimens after neoadjuvant chemotherapy].
    Tang F; Wu Y
    Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):8-12. PubMed ID: 19489218
    [No Abstract]   [Full Text] [Related]  

  • 8. The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer.
    Mukai H; Aihara T; Yamamoto Y; Takahashi M; Toyama T; Sagara Y; Yamaguchi H; Akabane H; Tsurutani J; Hara F; Fujisawa T; Yamamoto N; Ohsumi S;
    Breast Cancer; 2015 Jan; 22(1):5-15. PubMed ID: 25200171
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of locoregional outcome in HER2-overexpressing breast cancer treated with neoadjuvant chemotherapy.
    Arsenault D; Hurley J; Takita C; Reis IM; Zhao W; Rodgers S; Wright JL
    Am J Clin Oncol; 2015 Aug; 38(4):348-52. PubMed ID: 23799288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).
    Campbell JI; Yau C; Krass P; Moore D; Carey LA; Au A; Chhieng D; Giri D; Livasy C; Mies C; Rabban J; Sarode VR; Singh B; Esserman L; Chen YY
    Breast Cancer Res Treat; 2017 Aug; 165(1):181-191. PubMed ID: 28577078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
    Carey LA; Dees EC; Sawyer L; Gatti L; Moore DT; Collichio F; Ollila DW; Sartor CI; Graham ML; Perou CM
    Clin Cancer Res; 2007 Apr; 13(8):2329-34. PubMed ID: 17438091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI in residual tumor size measurement in patient with breast cancer receiving neoadjuvant chemotherapy calls for caution.
    Wu LM; Hu J; Xu JR
    Breast Cancer Res Treat; 2012 Aug; 135(1):319-20. PubMed ID: 22850894
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of Residual Disease With Molecular Breast Imaging in Patients Undergoing Neoadjuvant Therapy: Association With Molecular Subtypes.
    Menes TS; Golan O; Vainer G; Lerman H; Schneebaum S; Klausner J; Even-Sapir E
    Clin Breast Cancer; 2016 Oct; 16(5):389-395. PubMed ID: 27282845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trastuzumab after primary treatment for early stage HER2-positive breast cancer reduces recurrence.
    Dent R; Clemons M
    Cancer Treat Rev; 2006 Apr; 32(2):144-8. PubMed ID: 16517084
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of ErbB-1 and ErbB-2 to select endocrine therapy for breast cancer: will it play in Peoria?
    Pritchard KI
    J Clin Oncol; 2001 Sep; 19(18):3795-7. PubMed ID: 11559715
    [No Abstract]   [Full Text] [Related]  

  • 16. The Japanese Breast Cancer Society Clinical Practice Guideline for pathological diagnosis of breast cancer.
    Horii R; Honma N; Ogiya A; Kozuka Y; Fukuda T; Yoshida M; Ohsumi S; Mukai H;
    Breast Cancer; 2015 Jan; 22(1):59-65. PubMed ID: 25022266
    [No Abstract]   [Full Text] [Related]  

  • 17. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.
    De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L
    Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sometimes a great notion--an assessment of neoadjuvant systemic therapy for breast cancer.
    Davidson NE; Morrow M
    J Natl Cancer Inst; 2005 Feb; 97(3):159-61. PubMed ID: 15687353
    [No Abstract]   [Full Text] [Related]  

  • 19. Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer?
    Esteva FJ; Hortobagyi GN
    J Natl Cancer Inst; 2008 Apr; 100(8):521-3. PubMed ID: 18398093
    [No Abstract]   [Full Text] [Related]  

  • 20. [The development of neoadjuvant chemotherapy in breast cancer].
    Taguchi T
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):876-81. PubMed ID: 22705682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.